HomeATOS • NASDAQ
add
Atossa Therapeutics Inc
Previous close
$0.78
Day range
$0.74 - $0.80
Year range
$0.55 - $1.31
Market cap
95.56M USD
Avg Volume
587.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.25M | 44.89% |
Net income | -8.69M | -20.22% |
Net profit margin | — | — |
Earnings per share | -0.07 | -16.67% |
EBITDA | -9.25M | -44.91% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 51.84M | -30.66% |
Total assets | 58.01M | -27.01% |
Total liabilities | 8.22M | 41.91% |
Total equity | 49.79M | — |
Shares outstanding | 129.17M | — |
Price to book | 1.99 | — |
Return on assets | -37.75% | — |
Return on capital | -43.03% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -8.69M | -20.22% |
Cash from operations | -6.00M | -26.42% |
Cash from investing | -7.00K | 30.00% |
Cash from financing | — | — |
Net change in cash | -6.01M | -26.30% |
Free cash flow | -2.77M | 16.11% |
About
Founded
2008
Headquarters
Website
Employees
15
